-
EXCLUSIVE: New Alzheimer's Treatment? Promising Cannabinoid Compound Shows Hope, InMed CEO Says
Friday, June 21, 2024 - 3:41pm | 564Read More...InMed Pharmaceuticals is making strides in Alzheimer’s research with its development of a cannabinoid-based compound that aims to protect and rejuvenate brain neurons. During Benzinga’s virtual event on Thursday, InMed president and CEO Eric A. Adams shared detailed insights into the...
-
Health Care, Biotech Leaders To Unveil Cutting-Edge Innovations
Monday, June 17, 2024 - 2:01pm | 355Read More...On Thursday at 11 a.m. EST, Benzinga will host a Healthcare & Biotech Breakthroughs virtual conference. This online event will bring together industry leaders to discuss recent advancements in healthcare and biotechnology that are transforming patient care and creating new investment avenues....
